Bruna-MejÃas, A.; Silva-Bravo, V.; Moyano Valarezo, L.; Delgado-Retamal, M.F.; Nazar-Izquierdo, D.; Aguilar-Aguirre, I.; Nova-Baeza, P.; Orellana-Donoso, M.; Suazo-Santibáñez, A.; Gutiérrez-Espinoza, H.;
et al. The Adverse Effects and Use of Bevacizumab in Patients with Glioblastoma: A Systematic Review and Meta-Analysis. Pharmaceuticals 2025, 18, 795.
https://doi.org/10.3390/ph18060795
AMA Style
Bruna-MejÃas A, Silva-Bravo V, Moyano Valarezo L, Delgado-Retamal MF, Nazar-Izquierdo D, Aguilar-Aguirre I, Nova-Baeza P, Orellana-Donoso M, Suazo-Santibáñez A, Gutiérrez-Espinoza H,
et al. The Adverse Effects and Use of Bevacizumab in Patients with Glioblastoma: A Systematic Review and Meta-Analysis. Pharmaceuticals. 2025; 18(6):795.
https://doi.org/10.3390/ph18060795
Chicago/Turabian Style
Bruna-MejÃas, Alejandro, Vicente Silva-Bravo, Laura Moyano Valarezo, MarÃa Fernanda Delgado-Retamal, Diego Nazar-Izquierdo, Isidora Aguilar-Aguirre, Pablo Nova-Baeza, Mathias Orellana-Donoso, Alejandra Suazo-Santibáñez, Héctor Gutiérrez-Espinoza,
and et al. 2025. "The Adverse Effects and Use of Bevacizumab in Patients with Glioblastoma: A Systematic Review and Meta-Analysis" Pharmaceuticals 18, no. 6: 795.
https://doi.org/10.3390/ph18060795
APA Style
Bruna-MejÃas, A., Silva-Bravo, V., Moyano Valarezo, L., Delgado-Retamal, M. F., Nazar-Izquierdo, D., Aguilar-Aguirre, I., Nova-Baeza, P., Orellana-Donoso, M., Suazo-Santibáñez, A., Gutiérrez-Espinoza, H., Sanchis Gimeno, J., Bastidas-Caldes, C., & Valenzuela Fuenzalida, J. J.
(2025). The Adverse Effects and Use of Bevacizumab in Patients with Glioblastoma: A Systematic Review and Meta-Analysis. Pharmaceuticals, 18(6), 795.
https://doi.org/10.3390/ph18060795